Through this brief self-paced online eCourse, oncology professionals can better address the existing barriers to quality bladder cancer care for underserved populations and improve care coordination for improved health outcomes.

This webinar will provide an overview of the current insurance coverage landscape for CAR T-cell therapy. The discussion will focus on existing financial barriers and challenges that cancer programs face as they help patients and caregivers navigate CAR T-cell therapy.

In this series, experts share advice on the optimal management of immune-related adverse events (irAEs). Each session covers a different class of irAE-associated immunotherapies and includes evaluation and discussion of one or more case studies.

Bispecific antibodies are an emerging class of novel immunotherapy agents that have led to major breakthroughs in treating hematologic malignancies—and have promising applications for solid tumors. Learn about the mechanism of bispecific antibodies, discover existing and emerging therapies, and hear about the administration of the first FDA-approved bispecific antibody for the treatment of malignancy, including challenges and opportunities.

IO Institute

In this educational webinar series, hear from experts in the field discuss the basics of PROs, how PROs can be integrated into IO clinical care, and how PROs can be used in IO clinical trials.